Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-SILDENAFIL R | 20MG | TABLET | Resolved | 2020-07-14 | 2020-07-15 | 120259 |
| TEVA-SILDENAFIL R | 20MG | TABLET | Resolved | 2020-08-18 | 2021-03-25 | 122442 |
| TEVA-SIMVASTATIN | 80MG | TABLET | Resolved | 2020-08-06 | 2021-04-15 | 121885 |
| TEVA-SIMVASTATIN | 40MG | TABLET | Resolved | 2024-01-11 | 2024-07-04 | 215722 |
| TEVA-SIMVASTATIN | 80MG | TABLET | Resolved | 2019-10-03 | 2020-09-03 | 95390 |
| TEVA-SIMVASTATIN | 5MG | TABLET | Resolved | 2020-01-24 | 2020-06-05 | 104319 |
| TEVA-SIMVASTATIN | 10MG | TABLET | Resolved | 2022-09-07 | 2023-06-21 | 168749 |
| TEVA-SIMVASTATIN | 5MG | TABLET | Resolved | 2023-07-11 | 2024-09-05 | 198303 |
| TEVA-SIMVASTATIN | 20MG | TABLET | Resolved | 2023-07-11 | 2024-06-27 | 198306 |
| TEVA-SIMVASTATIN | 20MG | TABLET | Resolved | 2023-07-11 | 2024-07-11 | 198309 |
| TEVA-SIMVASTATIN | 5MG | TABLET | Resolved | 2023-08-17 | 2024-09-05 | 202252 |
| TEVA-SIMVASTATIN | 10MG | TABLET | Resolved | 2023-10-05 | 2024-07-04 | 206401 |
| TEVA-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-10-19 | 2024-07-18 | 207518 |
| TEVA-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-01-12 | 2023-07-12 | 180912 |
| TEVA-SIMVASTATIN | 80MG | TABLET | Resolved | 2023-01-12 | 2023-06-21 | 180915 |
| TEVA-SIMVASTATIN | 40MG | TABLET | Resolved | 2023-06-16 | 2023-06-21 | 195243 |
| TEVA-SIMVASTATIN | 20MG | TABLET | Resolved | 2017-08-02 | 2017-08-26 | 18004 |
| TEVA-SIMVASTATIN | 80MG | TABLET | Resolved | 2017-08-02 | 2017-09-19 | 18014 |
| TEVA-SITAGLIPTIN MALATE | 25MG | TABLET | Actual shortage | 2025-03-06 | 2025-04-10 | 252059 |
| TEVA-SITAGLIPTIN MALATE | 50MG | TABLET | Actual shortage | 2025-03-06 | 2025-04-10 | 252062 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| CLOXACILLIN SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14018 |
| CLOXACILLIN SODIUM FOR INJECTION | 2G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14021 |
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
| DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
| EPIRUBICIN FOR INJECTION | 2MG | SOLUTION | Discontinued | 2020-10-22 | 2020-10-24 | 126906 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106170 | ||
| EPTIFIBATIDE INJECTION | 0.75MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14024 |
| EPTIFIBATIDE INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106176 | ||
| EPTIFIBATIDE INJECTION | 2MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14027 |
| FLUDARABINE PHOSPHATE FOR INJECTION | 25MG | SOLUTION | Discontinued | 2025-10-22 | 2025-10-22 | 257579 |
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
| GEMCITABINE FOR INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106155 | ||
| GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14033 |
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81337 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81344 | ||
| HYDROCORTISONE SODIUM SUCCINATE FOR INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81330 | ||
| HYDROCORTISONE SODIUM SUCCINATE INJECTION | Discontinued | 2019-04-11 | 2019-04-11 | 81347 | ||
| LEUCOVORIN CALCIUM INJECTION | 10MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14036 |
| LINEZOLID INJECTION | Discontinued | 2020-02-13 | 2020-02-13 | 106173 |